23 December 2010
Fulminant Clostridium difficile colitis post total hip replacement
Mihaela S. Stefan, Ella GuptaDOI: 10.12659/AJCR.881362
Am J Case Rep 2010; 11:237-240
Abstract
Abstract
Background: Clostridium difficile-infection (CDI) is the predominant cause of nosocomial diarrhea. Approximately 300,000 new cases occur in hospitals in the United States each year and these rates nearly doubled between 2000 and 2003. There is also an increase in mortality and complications related to CDI.
Case Report: A 54-year-old male who underwent a total hip replacement developed diarrhea 2 days postoperative; he received cefazolin as perioperative antibiotic. Clostridium difficile (CD) enzymelinked immunosorbentassay (ELISA) toxin assay was negative, and he was sent home. After three weeks, he returned to the hospital with severe abdominal pain, watery diarrhea, severe sepsis, and multiple organ failure. CD toxin ELISA was once again negative, but colonoscopy demonstrated pseudomembranes in the transverse colon. Tissue culture assay was positive. Colectomy with end-ileostomy was performed and the patient had an excellent recovery.
Conclusions: Perioperative antibiotic has become standard for surgical site infection prevention, but it can be associated with the development of CD colitis. Prompt diagnosis and treatment are essential for a good outcome, and timely surgical intervention should be used in patients who are unresponsive to medical therapy.
Keywords: perioperative antibiotic, Colectomy, clostridium difficile colitis
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946869
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946427
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946551
Most Viewed Current Articles
21 Jun 2024 : Case report
94,176
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
51,416
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
28,562
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,092
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030